{"id":"W4282935821","doi":"10.1158/1078-0432.ccr-21-4020","title":"First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Genentech","keywords":"Medicine; Renal cell carcinoma; Internal medicine; Adverse effect; Pharmacokinetics; Cancer; Nausea; Agonist; Oncology; Gastroenterology; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002301362,0.0001187469,0.000453634,0.0001852914,0.0002903104,0.0000108732,0.0004183366,0.00004160403,0.0006361748],"category_scores_gemma":[0.0001766322,0.00007869297,0.00009933233,0.001229925,0.0004342004,0.00004269054,0.0002944954,0.001207033,0.000001148179],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005309102,"about_ca_system_score_gemma":0.0005087347,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002294537,"about_ca_topic_score_gemma":0.00541274,"domain_scores_codex":[0.996557,0.0006175836,0.0007787962,0.0004283336,0.001200526,0.0004177822],"domain_scores_gemma":[0.9986663,0.0003040618,0.0001447334,0.0006235627,0.0001699516,0.00009135447],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02754131,0.01004474,0.949754,0.00005919481,0.00007483109,0.00003896402,0.0008995294,0.0001661751,0.000152945,0.000007386676,0.0004467131,0.01081419],"study_design_scores_gemma":[0.04085121,0.01369539,0.9397453,0.0001896857,0.00001439189,6.432371e-7,0.002169366,0.00003851581,0.0001304864,0.00001998012,0.003043294,0.0001017298],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960619,0.0002371299,1.33667e-7,0.001100923,0.0001682571,0.00207729,0.0000306047,0.000008338787,0.0003154513],"genre_scores_gemma":[0.9987268,0.00005635241,0.000004538237,0.000194616,0.0000524137,0.0005689748,0.000007821744,0.00002548168,0.0003629976],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0133099,"threshold_uncertainty_score":0.6965668,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1139093973048907,"score_gpt":0.5092122895520722,"score_spread":0.3953028922471815,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}